KB1 XX
Alternative Names: KB1-XXLatest Information Update: 27 Nov 2023
At a glance
- Originator Krystal Biotech
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Unspecified